But, while implementing these new techniques in microbiology and genomics, research and pharmaceutical companies in life sciences face the following challenges:
The commercial environment is constantly getting harsher, as the government is imposing new cost constraints on pharmaceutical industries and scrutinizing the value medicines offer much more carefully. Even healthcare payers want new therapies that are clinically and economically better than the existing alternatives.
The life sciences industry is using the same discovery and development processes over the years, and this has affected its scientific productivity.
The current management culture, strategies, and development models on which the life sciences industry relies on are the same ones it has traditionally relied on. Hence, these models are not adequate for bringing in business value.
Allerin’s Solution Features
Allerin’s Big Data solution can effectively help in accelerating product and service development ranging from genomic sequencing and analysis to finding out causes of a disease and its progression. Our system facilitates the ability to use the present internal and external data for making decisions about a potential new product, thereby differentiating an organization from its competitors.
Our Big Data analytics system can help in enhancing clinical trials for a new drug. It can precisely show researchers and experts the most suitable patients for recruitment to a drug trial. Thus, results from clinical trials can be collected and analyzed in real time with our Big Data solution, which can significantly shorten the time-consuming part of the product lifecycle.
Allerin’s Big Data analytics solution can help organizations in measuring and improving marketing effectiveness at any point in a sales lifecycle, thereby providing competitive product analysis and customer support. Thus, our system can improve life science organizations’ operational efficiency and can effectively identify internal problems or barriers to performance.
Benefits of Allerin’s Solution
Insights for Pharmaceutical Safety and Innovation
For proving the continued safety and efficacy of a major drug, pharmaceutical companies can use Allerin’s Big Data solution to acquire better insights in drug combinations and usage. This will enable an efficient research environment that can facilitate faster loading and analysis of prescriptions patient records.
Expanded Safety Analysis for Life Sciences
With Allerin’s Big Data solution, life sciences companies can significantly improve safety analysis of conditions by analyzing electronic medical records data and thereby provide accurate conversions from sample data to the full data set in real time.
Supply Disruptions Predictive Analytics
Allerin’s Big Data solution consists of predictive models that can use a combination of internal and external data for reducing unforeseen shortages in availability of drugs, thereby preventing impact on customer service levels and lost sales revenues.
With our Big Data solution, life sciences organizations will have the strategic data and intelligence for developing new applications, making them smarter and enabling them to provide durable and effective medicines.
Our life sciences solutions team can help pharmaceutical companies identify their specific pain points and tweak our solution accordingly. Our solution will, thus, help you take better business decisions and react faster during critical times while eliminating human intervention in routine activities. To know more about our solution, contact Allerin .